SokRom via Getty Images
Shaun Lowe via Getty Images
At the heart of Canada's prescription drug affordability crisis are the long approval processes and prospective reimbursement lists. Improving customer choice by allowing earlier access to new pharmaceuticals would be a silver bullet to reducing drug costs per treatment.
While the incomes of Canada's wealthiest are increasing, the absolute wealth of our poorest is decreasing. As this gap grows, so too do the differences in people's health risks, care and outcome. The poorer people are in Ontario, the more likely they are to have shorter lifespans, to be overdue for screening tests and to suffer from multiple chronic health conditions.